The data reviewed in this paper show that CIDP is associated with antibodies mainly against paranodal proteins (NF155, CNTN1, and rarely Caspr) and to a lesser extent NF186 in around 10% of patients. This evidence concerns the gene CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy.